Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2025-12-29 @ 5:16 PM
Study NCT ID:
NCT07020832
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-06-13
First Post:
2025-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
Sponsor:
Apellis Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-06
First Submit QC Date:
None
Study First Post Date:
2025-06-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-06
Last Update Post Date:
2025-06-13
Last Update Post Date Type:
ACTUAL